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Abstract
Background: The United Arab Emirates (UAE) government aspires to build a world class health system to improve
the quality of healthcare and the health outcomes for its population. To achieve this it has implemented extensive
health system reforms in the past 10 years. The nature, extent and success of these reforms has not recently been
comprehensively reviewed. In this paper we review the progress and outcomes of health systems reform in the
UAE.
Methods: We searched relevant databases and other sources to identify published and unpublished studies and
other data available between 01 January 2002 and 31 March 2016. Eligible studies were appraised and data were
descriptively and narratively synthesized.
Results: Seventeen studies were included covering the following themes: the UAE health system, population health, the
burden of disease, healthcare financing, healthcare workforce and the impact of reforms. Few, if any, studies prospectively
set out to define and measure outcomes. A central part of the reforms has been the introduction of mandatory private
health insurance, the development of the private sector and the separation of planning and regulatory responsibilities
from provider functions. The review confirmed the commitment of the UAE to build a world class health system but
amongst researchers and commentators opinion is divided on whether the reforms have been successful although
patient satisfaction with services appears high and there are some positive indications including increasing coverage of
hospital accreditation. The UAE has a rapidly growing population with a unique age and sex distribution, there have been
notable successes in improving child and maternal mortality and extending life expectancy but there are high levels of
chronic diseases. The relevance of the reforms for public health and their impact on the determinants of chronic diseases
have been questioned.
Conclusions: From the existing research literature it is not possible to conclude whether UAE health system reforms are
working. We recommend that research should continue in this area but that research questions should be more clearly
defined, focusing whenever possible on outcomes rather than processes.
Keywords: Health system, Reform, Middle East, United Arab Emirates, Health insurance, Privatization
* Correspondence: iain_blair@uaeu.ac.ae
4Institute of Public Health, College of Medicine and Health Sciences, United
Arab Emirates University, PO Box 17666, Al Ain, United Arab Emirates
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Koornneef et al. BMC Health Services Research  (2017) 17:672 
DOI 10.1186/s12913-017-2597-1
Background
The United Arab Emirates (UAE) is a young nation,
established in 1971 as a federation of seven Emirates:
Abu Dhabi, Dubai, Ajman, Umm Al Quwain, Sharjah,
Fujairah and Ras Al Khaimah (Fig. 1). This newness has
allowed its leaders to deliberately plan for the develop-
ment of UAE society in order to strengthen national
unity, promote continuous economic growth and per-
sonal health and wellbeing [1].
As recently as the late 1960s, in the UAE, it was re-
ported that only half of newborn babies survived and
one in three mothers died during childbirth [2]. Almost
50 years later many health outcomes are on par or even
better than those seen in developed countries. The ma-
ternal mortality ratio (MMR) is now 8 per 100,000 live
births (in contrast to an MMR of 14 in the USA) and
the infant mortality rate is 5.6 per 1000 live births (5.8
in the USA) [3]. Healthcare in the UAE has benefited
from rapid economic growth and there has been a sig-
nificant increase in the number of healthcare facilities
and healthcare professionals and in levels of service use.
For example, between 2011 and 2015 healthcare spend-
ing in the UAE grew by 10% to US$ 11 billion [4].
In 2014, the Vice President and Prime Minister of the
UAE, His Highness Sheikh Mohammed bin Rashid Al
Maktoum, launched an ambitious set of plans with the
overall goal of making the UAE one of the best countries
in the world by 2021, the 50th anniversary of its founda-
tion. The UAE National Agenda 2021 consists of a com-
prehensive set of key performance indicators (KPI) with
specific targets and clear pathways for achieving those
targets [5]. For example, in 2016, the UAE Government
announced the appointment of a Minister of Happiness
whose task it is to ensure that the UAE is ranked among
the top five countries in the world according to the
World Happiness Report [6].
The improvement of the health of its citizens and the
performance of the healthcare system form one of seven
headings of the UAE national strategy. The KPIs include
population health targets, such as increasing life expect-
ancy and reducing tobacco consumption, as well as
more structural and organizational targets, such as the
Fig. 1 Map of United Arab Emirates showing the seven Emirates
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regulatory requirement for all healthcare facilities to be
externally accredited [5]. Overall, the UAE aims to be
ranked amongst the top 20 countries in the world, ac-
cording to the Legatum Prosperity Indicator. In 2015 the
UAE was ranked 34th globally, an improvement from
37th place in 2014 [7].
Given its starting point, it is remarkable what has been
achieved in the UAE in the last four decades. However
since the early 2000s the UAE has been involved with an
ambitious program of health system reforms to further
improve health and health services and to address cost
and quality challenges. These reforms have focused on
the introduction of private health insurance and encour-
aging the growth of private health provision against a
back-drop of rapid population growth and a rising
prevalence of chronic disease and chronic disease risk
factors including obesity, low levels of physical activity
and diabetes [8].
The purpose of this paper is to describe the main
healthcare challenges and public health issues in the
UAE and review the progress and outcomes of health
systems reform. This will be achieved by reviewing sec-
ondary data from peer-reviewed journal publications and
reports of government agencies and related health
organizations.
Even though the term health system reform is regularly
used, it is rarely defined in any operational way [9]. In
this paper we have defined health system reform as “sus-
tained, purposeful change to improve the efficiency,
equity and effectiveness of the health care sector” [10].
Methods
Data for this review were obtained by means of a sys-
tematic search of the published literature using defined
keywords, conducted according to Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [11]. MEDLINE (accessed by
PubMed), EMBASE and PsycINFO electronic databases
were searched covering the period from 2002 to April
2016 using a combination of the following MESH terms,
free-text words, and entry terms: UAE; United Arab
Emirates; Dubai; Abu Dhabi; healthcare quality, access
and evaluation; healthcare reform, health system reform,
health sector reform. In addition, reference lists of pub-
lished studies were searched manually for relevant arti-
cles. To minimize publication bias and improve the
usefulness of our review we also conducted a thorough
analysis of existing, publicly available “grey” literature by
means of personal contact with senior officers at health
authorities, government agencies and health sector orga-
nizations and a review of publications and reports from
health policy centers, the healthcare business sector and
key international sources. These sources included the
World Health Organization (WHO) and its regional
office for the Eastern Mediterranean (EMRO), the Or-
ganisation for Economic Co-operation and Development
(OECD), the World Bank, and local sources such as the
Health Authority Abu Dhabi (HAAD), Dubai Health
Authority (DHA), Ministry of Health and the Federal
Competitiveness and Statistics Authority. Finally, a small
number of other sources were reviewed from local
“think tanks” and consultancy and research firms. These
included Ernst and Young, Colliers International, The
Economist Intelligence Unit, US-UAE Business Council,
Joint Commission International and Sheikh Saud bin
Saqr Al Qasimi Foundation for Policy Research. Eligible
studies were those that focused on the UAE health sys-
tem. Excluded studies were those that focused on health-
care in the wider region, studies that were published
before 2002, articles that were not available in English
and duplicate studies or those that formed part of a
larger study. Two reviewers (EK, IB) independently
screened the titles and abstracts of identified studies and
duplicates were removed. Studies considered eligible for
full text screening were retrieved for full review. The re-
viewers independently assessed the papers for eligibility
and quality, and then met to resolve any disagreements
regarding eligibility and/or quality. The key features of
the studies were summarized using a data extraction
form that recorded first author name, year, study design,
setting, theme and key findings. A descriptive and narra-
tive synthesis of the studies was carried out.
Results
We screened 353 published articles and 17 met our in-
clusion criteria (Fig. 2). Of these, three related to Dubai,
eight to Abu Dhabi and six were UAE-wide and all were
published after 2010. There were four cross-sectional
studies, six policy reviews, three data reviews, two case
studies and two literature reviews. From a careful read-
ing of the selected papers it was possible to classify the
content into six categories or themes. The six themes
are: the UAE health system, population health, the bur-
den of disease, healthcare financing, healthcare infra-
structure and workforce and the impact of reforms
(Table 1). The findings are summarized under these
headings in the following sections. For the sake of clar-
ity, while acknowledging the possible inferior quality, we
have included the grey literature, appropriately refer-
enced, it in our summary along with the published
literature.
The UAE health system
Ten of the included papers discussed the UAE health
system. Improving the quality of healthcare as well as
the actual health outcomes for its citizens has been a
key strategic goal of the UAE government since its for-
mation in 1971. Dubai and Abu Dhabi have their own
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health authorities for licensing, regulation and quality
assurance. The Federal Ministry of Health (MOH) fulfils
these functions in the other five emirates. In addition
the MOH carries out certain high level functions for all
Emirates [12].
In both Dubai and Abu Dhabi around 70% of out-
patient visits are made to private healthcare facilities
while for inpatient activity in private facilities the pro-
portion is 40% in Abu Dhabi and 60% in Dubai [13, 14].
In the remaining five Emirates, the Ministry of Health is
both the regulator as well as the main provider of most
healthcare services. According to the most recent data,
in 2014, there were 36 government and 79 private hospi-
tals in the UAE, an increase of 25% since 2009 [15].
In 2006 the government of Abu Dhabi embarked on a
significant health system reform program with a clear
focus on the redesign of the healthcare financing and
regulatory system [8]. The regulatory function (the re-
sponsibility of Health Authority Abu Dhabi) was sepa-
rated from service provision (the responsibility of the
Abu Dhabi health service company, SEHA). Also the
new system required all persons to have private health
insurance and provides a centralized platform for auto-
mated claims processing and an improved level of ac-
countability and transparency because of market
regulation [16]. One study reported large differences in
healthcare utilization rates between UAE nationals who,
on average, used outpatient clinical services once per
month compared to expatriates where usage rates were
3–4 times less [17].
In 2014, Dubai also began to introduce mandatory
health insurance, with about one third of its residents
currently estimated to be insured [18]. A recent review
of the Dubai health system concluded that more effort
should be made to move from curative to preventive ser-
vices [19]. The same review also found that the current
system of care encouraged excessive hospital utilization
and recommended a reorientation towards outpatient,
home based and day surgery services.
It has been reported that the rest of the UAE will fol-
low soon with the introduction of mandatory private
health insurance but a final date has not been set [20].
The MOH is considering introducing health insurance
but has not yet done so. In the northern Emirates, the
private sector is less well developed than in Dubai and
Abu Dhabi and the quality and cost of services varies be-
tween these two Emirates and the remainder of the
country [17].
Five of the studies examined the UAE health regula-
tory system with one highlighting the trend towards
regulatory fragmentation as a serious challenge to the
future of healthcare in the UAE [18]. A further study re-
ported the lack of regulatory control and a lack of com-
petition between insurance companies as the two main
obstacles to achieving greater cost efficiency in the
healthcare market [21]. Researchers who evaluated the
regulatory system for healthcare professionals concluded
that the UAE had made significant progress in develop-
ing and implementing best regulatory practice [12].
Other research on the regulation of healthcare services
Fig. 2 Flow diagram of the search and selection process
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Table 1 Summary of study characteristics included in the literature search
First author,
Year
Study Design /
Method
Focus Topics Key Findings
Al Maskari, 2010
[33]
Retrospective
cohort study
Dubai Healthcare Financing Average costs (without complications): 1605 USD, with complications 5645
USD
Burden of disease
(diabetes)
61% of all diabetes patients in the cohort reported to have suffered poor
health
during the past month
Al Zaabi, 2014
[36]
Retrospective
cohort study
Abu
Dhabi
Healthcare Financing Asthma treatment in the UAE costs around 200 USD per capita
Burden of disease
(asthma)
Crude prevalence of asthma is 4.8%, much lower than expected
Blair, 2012 [21] Data review UAE Burden of disease Substantial population growth
Population Health Data quality needs to be improved
Blair, 2012 [27] Healthcare
policy review
UAE UAE Health System Review of UAE healthcare system 2000–2010
Population Health Dramatic population growth, young population
Burden of disease Main causes of death: road injury, health and cerebrovascular diseases
Healthcare Financing Expenditure has grown from 1.7 billion USD in 2000 to 9.5 billion USD in
2011
Healthcare
infrastructure and
workforce
Largely expat clinical workforce (>85%)
Impact of reforms Satisfaction appears high but citizens still opt for treatment abroad
Al Hosani, 2014
[31]
Healthcare
policy review
UAE Burden of disease National neonatal screening program
Brownie, 2015
20]
Regulatory
policy review
UAE Healthcare infrastructure
and workforce
Brief historical overview of regulation and licensing in the UAE
UAE Health System Move towards central, consistent regulation and licensure
Hajat, 2012 [34] Retrospective
cohort study
Abu
Dhabi
Burden of disease This population-wide cardiovascular screening program demonstrated a high
cardiovascular burden for our small sample in Abu Dhabi
Hajat, 2012 [29] Healthcare
policy review
Abu
Dhabi
Burden of disease Largely unhealthy lifestyle - lack of physical activity, poor diets & tobacco
consumption
Population Health Weqaya - a program aimed at improving population health (cardiovascular)
Healthcare Financing Diabetes may cost up to $1.1 billion per year in Abu Dhabi
UAE Health System Weqaya program - screened 94% of national population
Hamidi, 2014
[19]
Focused
literature
review
Abu
Dhabi
Healthcare Financing In Abu Dhabi there has been a significant growth in demand for healthcare
since 2007
UAE Health System Strategies are in place designed to slow the rise in spending
Hamidi, 2015
[38]
Data review Abu
Dhabi
UAE Health System The health care model has not fully matured yet and needs to focus on
creating a sustainable model that is affordable and provides high quality, safe
care
Hamidi, 2015
[17]
Data analysis Dubai UAE Health System Changes required to move from curative to preventive care and from
inpatient to day care, outpatient and home-based care
Healthcare
infrastructure and
workforce
Cost containment for pharmaceuticals
Healthcare Financing Strengthen long-term care
Koornneef, 2012
[14]
Healthcare
policy review
Abu
Dhabi
Impact of reforms Limited information available, some evidence of improved access and patient
satisfaction
UAE Health System Three key characteristics: centralized regulatory system, mandatory insurance
and competition
Loney, 2013
[25]
Literature
search
UAE Population Health UAE has significantly invested resources into population-based control
measures
Burden of disease Top four priorities: cardio, injury, cancer, respiratory diseases
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in Abu Dhabi concluded that several challenges
remained to be addressed, in particular with respect to
quality improvement [18]. Interestingly, Abu Dhabi’s
healthcare regulator itself, HAAD, concluded in 2013
that “the current model of care in Abu Dhabi does not
adequately support self-care or prevention and screening
programs and diagnostic services are not integrated into
care plans. Also, patients have undirected access to ser-
vices and specialty care which leads to inappropriate use
and, in turn, over-supply of services” [14].
Population health
Five studies addressed this topic. The UAE population
can be characterized as young and fast growing. The
UAE population pyramid is remarkable in term its
youthfulness and the high proportion of male expatriates
[22]. Overall, the median age is 30 but amongst UAE na-
tionals, who only account for approximately 11% of the
population, 79% are aged less than 35 [3, 15]. Expatriates
are typically of working age but despite this the majority
are aged 35 or less. Population growth rate has also been
remarkable. In 1950 the population was 70,000, in 1968
it was 180,000 but this has now grown to 9.16 million
[23, 24]. Over the last 10 years the population has more
than doubled, mainly due to large net in-migration of
expatriates. Since the population of nationals is small,
the contribution of the birth rate amongst nationals to
overall population growth is also small. For example, be-
tween 2010 and 2014, the UAE population grew by over
one million. However, during this four-year period, the
national population increase by only 126,609 (births
minus deaths). In other words, population growth
amongst nationals contributed only 11.7% of total popu-
lation growth. By comparison, natural growth amongst
expatriates contributed 19% of total population growth
and net in-migration contributed the remaining 70%.
The great majority of the expatriate population in the
UAE are male, young and originally from Asian coun-
tries. For example, it is estimated that approximately 2.6
million Indian nationals reside in the UAE [25]. The
total fertility rate (average number of children that
would be born to a woman over her lifetime) decreased
from 4.4 in 1990 to 2.4 in 2010 [26]. During the same
period, the average life expectancy improved from
72 years to 77 years [27]. The unique characteristics of
the UAE population should play a major role in the de-
velopment and implementation of health strategies and
policies. Clearly child and maternal health services,
youth services, health promotion and preventative ser-
vices and occupational health services should be prior-
ities [17]. A recurring theme from the studies that we
reviewed is the need to improve health data collection
and reporting [17, 22]. For example, birth and death data
are reported but not by nationality, making it difficult to
determine what, if any, specific, targeted strategies are
required. In summary, the demographic transition in the
UAE is one characterized by declining birth and death
rates which with high net in-migration has resulted in
significant population growth [28]. There has been a sec-
ond health transition in the UAE in recent decades, an
epidemiological transition, characterized by a decline in
communicable diseases and a rise in non-communicable
or chronic diseases, such as heart disease, diabetes and
cancer [28]. This is described in the following section.
The burden of disease
Eight studies discussed UAE mortality, morbidity and risk
factors. As mentioned earlier, the UAE Government has
set itself a number of challenging targets through its Vi-
sion 2021 strategy [5]. Of particular relevance are the tar-
gets to reduce the number of deaths (per 100,000
population) from cardiovascular disease from 297 to 158.
Other targets relate to a reduction in the number of adults
with diabetes (from 19 to 16%), a reduction of obesity
Table 1 Summary of study characteristics included in the literature search (Continued)
Mosaad, 2014
[28]
Healthcare
policy review
UAE UAE Health System Risk factors: ageing population, population growth, health risk factors
Healthcare
infrastructure and workforce
Lack of clinical staff, hospital beds and referral network
Impact of reforms Progress is “underway” in the UAE with a focus on quality, screening and
competition. However, the focus is not on prevention
Osenenko km
et al., 2015 [50]
Retrospective
cohort study
UAE Population Health Greater understanding of the factors leading to high adherence to guidelines
would be useful
Impact of reforms Compared to international benchmarks, the patients in Dubai received similar
quality outcomes
Sharif, 2011 [44] Case study Dubai UAE Health System Review of the necessary changes in the healthcare system in Dubai to
accommodate population growth and burden of disease
Vetter, 2012
[15]
Case study Abu
Dhabi
Healthcare Financing Strong regulatory focus on cost containment
UAE Health System Many changes since 2006, in particular introduction of mandatory insurance
and the establishment of a regulator
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amongst children (from 13 to 12%) and an increase in the
healthy life expectancy (from 67 to 73 years). Since its in-
dependence in 1971, the UAE has made significant pro-
gress with increased life expectancy and lower maternal
and infant mortality rates [29]. However, despite these
achievements, the UAE faces a number of challenges in-
cluding rising rates of non-communicable diseases such as
diabetes, cardiovascular diseases and cancer [26].
The UAE has made progress with the control and pre-
vention of communicable diseases, through a strong focus
on immunization, surveillance, mandatory reporting and
effective treatment [26]. The mandatory screening of all
expatriate workers linked to the visa application and re-
newal process has also had an effect [30]. The national
neonatal screening program for new born babies has been
successful with an increased uptake from 50% in 1998 to
95% in 2010 resulting in early detection, treatment and
follow up [31]. The WHO currently estimates that world-
wide around 67% of all deaths are now attributable to
non-communicable diseases, with the leading causes of
death reported as cardiovascular diseases, injury and can-
cer [32]. This is also the situation in UAE, where mortality
from non-communicable diseases (NCDs) among those
aged 60 years or younger is amongst the highest in the
world. The leading causes of premature deaths in the UAE
are road injury, cardiovascular disease and respiratory ill-
nesses [17]. In the studies that we reviewed, authors iden-
tified the determinants of this health loss as unhealthy
lifestyles (physical inactivity, high caloric intake) and a lack
of health system focus on prevention, chronic disease
management, early stage interventions and inadequate
treatment options for NCDs and their complications. As
solutions, these authors proposed further research, the es-
tablishment of reliable surveillance and monitoring pro-
grams and improved training and education for healthcare
professionals [26, 31, 33].
We found five studies that described interventions to
address the UAE burden of NCDs. One such interven-
tion is the Abu Dhabi Weqaya program that aims to
screen adults for cardiovascular disease risk factors
followed by targeted follow up, treatment and secondary
prevention [34]. Weqaya has confirmed a high preva-
lence of cardiovascular disease risk factors amongst the
adult population. Following the successful implementa-
tion of screening in a small, high-risk population using
newly agreed UAE screening guidelines other re-
searchers have recommended a national diabetes screen-
ing program [35]. In the review we found a number of
studies that reviewed the direct and indirect economic
burden of selected diseases, including asthma and dia-
betes [33, 36]. The economic burden of asthma was esti-
mated at US$ 29 million in Abu Dhabi and US$ 24
million in Dubai, an annual per capita cost of around
US$ 200, about half the cost compared to European or
North American benchmarks. One of the most cited ar-
ticles in the review assessed the direct medical costs of
diabetes care, the annual cost of diabetes without com-
plications was US$ 1605, similar to the costs in most
western countries but the treatment costs of diabetes
mellitus with complications was up to 9.4 times higher
[33]. The authors of these papers that reviewed the eco-
nomic costs of high burden diseases typically recom-
mended improvements in management including
nationwide early screening and rapid implementation of
best-practice clinical guidelines as a means to improve
outcomes while controlling costs.
Healthcare financing
Seven studies discussed healthcare financing. Recently
published WHO data indicates that in the UAE over the
last 12 years, total expenditure on health as percentage
of gross domestic product (GDP) has increased by over
36% (from 2.2% of GDP in 2000 to 3.0% in 2012) [3]. In
absolute terms, the UAE’s GDP rose from US$104.3 bil-
lion in 2000 to US$372.3 billion 2012, meaning that
health spending grew from US$2.3 billion to US$ 11.2
billion. More recent reports show a further increase to
US$13.6 billion in 2014 with an expected budget of
US$25.7 billion by 2024 [37]. In Abu Dhabi, mandatory
health insurance for all nationals and expatriates has
been the major driver of its healthcare reform since
2006 [38]. There are three different insurance schemes:
two for expatriates (Basic and Enhanced) and one for
UAE nationals (Thiqa). In 2011 there were 15.3 million
insurance claims with an average cost per claim of $105
giving a total insurance bill of US$ 1.6 billion. This had
grown to over 22 million claims and US$2.9 billion by
2014 (Additional file 1) [14]. Even though there has been
a steady rise in the number of claims (Fig. 3) as well as
the overall cost, some researchers have argued that this
is appropriate because universal health insurance cover
and transparent, standardized payment rules and regula-
tion allow for better control of cost, ensure that health
needs are met and offer patients the freedom to choose
provider [8, 16]. However, other researchers have con-
cluded that increasing claims and costs signal the need
for further changes to ensure long-term financial sus-
tainability [38]. The WHO and other sources estimate
that the UAE government spent almost a quarter of its
total healthcare expenditure in 2010 to send its citizens
abroad for medical care [16, 32]. Dubai Health Authority
for example sponsored 2717 patients in 2014 for treat-
ment abroad, an increase of almost 2000 in 10 years
(Table 2) [13]. While in 2013, Health Authority Abu
Dhabi sponsored over 1400 patients [14]. Also there are
other referral sources for UAE nationals who wish to be
sent abroad for medical treatment, including the
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Ministry of Health, Ministry of Defense, Abu Dhabi Na-
tional Oil Company (ADNOC) and other large compan-
ies [8].
At the same time, the UAE is working to attract
medical tourists to its healthcare facilities, in particu-
lar its highly specialized hospitals. For example in
2012, Dubai attracted over 500,000 medical tourists, a
figure that is expected to grow annually by 10–15%
[39]. In the UAE the level of out-of-pocket (OOP)
healthcare expenses is relatively low in comparison to
other countries in the region and the rest of the
world. At 20% the OOP is just above the OECD aver-
age of 17% indicating a reasonable level of financial
protection [40]. A number of studies have commented
on the low levels (ranging from 4 to 15%) of generic
prescribing and the high use of branded pharmaceuti-
cals with the inevitable implications for increasing
costs [41, 42]. In the UAE, data on health care spend-
ing is not yet available in a standardized format. The
claims based data for Abu Dhabi shown in Table 2
contains only the reimbursement cost not the actual
cost. Denials, co-payments and sole payments are not
included. Also cost estimates typically exclude capital
expenditure, funding provided through other govern-
ment institutions such as the Ministry of Defense and
ADNOC and cash payments. Table 3 gives a break-
down and estimate of the healthcare expenditure in
the UAE based on our findings from this review [19,
43].
Healthcare infrastructure and workforce
Five studies addressed this topic. Hospital bed and phys-
ician and nurse numbers have increased in the past dec-
ade generally keeping pace with the growth of the
population (Table 4). The total number of hospital beds
has more than doubled and there has almost been a
five-fold increase in the number of nurses and physicians
[15]. A number of case studies have reviewed the
current demand and supply and made recommendations
for future configuration and capacity. Few of these stud-
ies reported that additional increases in hospital beds
and staff numbers were justified [17, 37, 44]. However,
Health Authority Abu Dhabi estimated that a further
4800 physicians and 13,000 nurses would be required for
Abu Dhabi alone to meet the projected 2022 demand
[14]. The goal for the UAE is to bring the level of nurses
and physicians to a world class level, which means that
the number of nurses need to be almost doubled and
the number of physicians needs to increase by 20% [5].
Despite these reported shortfalls in capacity and re-
sources, the authors were unable to find any studies that
analyzed the potential effects of the reported lack of
manpower and hospital beds. On the contrary, a number
of studies, as well as a report from the Abu Dhabi regu-
latory authority described potential oversupply in certain
areas [14, 17]. Another challenge is the high rate of turn-
over of clinical staff, with one report estimating that
around 15% of physicians and 13% of nurses left their
positions in the UAE in 2012 alone [45].
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Fig. 3 Health insurance claims by type of insurance scheme, Abu Dhabi, 2009–2014
Table 2 Funding of International Patient Care by Dubai Health
Authority
Year No. UAE Patients who received
medical treatment outside UAE
Average cost
per patient
(US$)
Total cost
(US$)
2004 808 40,436 32,672,262
2005 679 54,768 37,187,738
2006 863 57,221 49,381,471
2007 946 51,499 48,717,711
2008 850 75,204 63,923,706
2009 1073 59,128 63,444,414
2010 975 68,392 66,682,561
2011 1428 57,766 82,489,373
2012 1819 50,681 92,189,101
2013 2010 46,921 94,311,172
2014 2717 44,142 119,932,970
Source: Dubai Health Authority’s Annual Reports [43]
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The impact of reforms: Quality
Only three of the studies focused on the impact of
health system reforms. Although a number of re-
searchers have commented that it is too early to say
whether the UAE health system reforms that have been
in place over the past 10 years have achieved the desired
outcomes, there is evidence of a positive trend [8, 17]. A
recent study in a large hospital in Abu Dhabi found a
decrease in reported clinically significant adverse events
in one department (pediatrics) over a 4 year period [46].
This decrease coincided with the reform of its residency
training program, leading to the researcher’s conclusion
that “it is quite likely that our residents are providing
better patient care”. In Abu Dhabi, a study into percep-
tions and attitudes towards medical research amongst
focus group participants noted that the UAE has one of
the best healthcare systems in the region [47]. The UAE
has also witnessed a significant growth in Joint
Commission International (JCI) accreditation [48]. JCI
accreditation has become increasingly important in the
UAE, where a growing number of providers have be-
come accredited (Table 5) [49]. It is estimated that cur-
rently 47% of healthcare facilities are accredited and the
UAE government’s ambition is to achieve 100% accredit-
ation by 2021 [5]. In our review we found few studies
that reported quality and outcomes of care. However, in
one study in Dubai that reviewed the quality of care for
diabetic patients, using a standardized assessment, the
researchers found a number of differences when com-
pared to the US benchmark and recommended a nation-
wide benchmarking program [50]. Another study found
that while a private hospital maintained its performance
following JCI accreditation, accreditation did not con-
tribute to an overall, sustained improvement [51]. Fi-
nally, in our review, we found that studies that examined
patient satisfaction generally reported consistently high
levels compared to other countries [8, 17].
Discussion
This review has highlighted the ambition and commit-
ment of the UAE to build a world class health system
and has catalogued the major reforms that have been
implemented in the past decade to achieve this. The
paucity and limited scope of the studies means that it is
not possible to conclude whether the reforms are work-
ing although patient satisfaction with services appears
high and there are some isolated examples of quality
improvement.
The UAE health system is not a single system, rather
there are several systems and of these the three main
systems are operated by the health authorities of Abu
Dhabi and Dubai and the Ministry of Health (MOH).
These systems have expanded in the past 10 years in line
with the growth of the population and increases in na-
tional income and have been subjected to major reforms
aimed at improving public health and quality while
Table 4 UAE healthcare infrastructure, by category, Government
and private, 2005–2014
2005 2010 2014
Government*
Hospitals 26 34 36
Beds 4273 7029 7493
Physicians 2105 5031 6504
Nurses 6132 10,875 16,547
Private
Hospitals 37 58 79
Beds 1546 2556 4164
Physicians 1143 7866 10,165
Nurses 1866 10,611 16,882
Total
Hospitals 63 92 115
Beds 5819 9585 11,657
Physicians 3248 12,897 16,669
Nurses 7998 21,486 33,429
Source: UAE Federal Competitiveness and Statistics Authority
*Includes Ministry of Health, Ministry of Interior, Ministry of Defense, Abu
Dhabi Health Authority, Dubai Health Authority and ADNOC [16]
Table 5 Joint Commission International accredited facilities,
UAE, 2007–2015
Year No of healthcare facilities with JCI accreditation
2007 14
2008 18
2009 33
2010 42
2011 49
2012 55
2013 82
2014 102
2015 116
Source: Joint Commission International
Table 3 UAE total healthcare expenditure (Billion US$), by
Emirate, 2014
Healthcare Expenditure (Billion US$)
Abu Dhabi 4
Dubai 3.5
Northern Emirates 2.5
International Patient Care 3.6
Total 13.6
Source: Dubai Health Authority, Health Authority Abu Dhabi, World Health
Organization, US UAE Business Council
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keeping costs at sustainable levels, thereby achieving a
world class health service. The main element of the re-
forms have been a move to mandatory private health in-
surance for all citizens and expatriates, the development
of the private sector to deliver services and the separ-
ation of planning and regulatory responsibilities from
provider functions. These reforms have moved at differ-
ent speeds, being most complete in Abu Dhabi, in the
development phase in Dubai and just commencing in
the MOH. This patchy implementation has highlighted
variations in access, affordability and quality across the
Emirates. Amongst researchers and commentators opin-
ion is divided on whether the reforms have been suc-
cessful. Few, if any, studies have prospectively set out to
define and measure outcomes and while some re-
searchers have expressed optimism others have been
more critical. The relevance of the reforms for public
health and their impact on the determinants of chronic
diseases have been questioned with some researchers cit-
ing market failure and oversupply.
The UAE has a rapidly growing population with a
unique age and sex distribution. There is an unusually
high proportion of young people and expatriates of
working age, small numbers of older persons and rapid
year on year growth due to high net in-migration. It
might be expected that the unique characteristics of the
population would be a major factor to be considered
when planning and implementing health services but
there is little published research to support this. While
child and maternal health services are well developed,
there is little published evidence of needs analysis in the
areas of youth services, health promotion, preventative
services and occupational health services. Also health
data is not collected and reported in a way that allows
the health needs of these population sub-groups to be
defined.
The UAE has passed through the epidemiological tran-
sition with impressive reductions in health loss from in-
fections and neonatal and nutritional disorders but an
increasing burden of non-communicable disease (NCD)
notably cardiovascular disease (CVD), diabetes and road
injury. The lifestyle risk factors for these diseases (obes-
ity, low physical activity) are at high levels. From our re-
view there is evidence of high level commitment to
addressing these issues. The Abu Dhabi Weqaya pro-
gram set out to identify and manage individual CVD risk
factors but after the initial report describing the program
and presenting baseline data there have been no updates
on outcomes, effectiveness or recommendations to ex-
tend the program to the whole UAE adult population.
There is good evidence for the considerable cost burden
that NCDs place on health budgets and bench-marking
has shown that the situation in the UAE is comparable
to that in other high income countries. However there is
also evidence that in the management of NCDs inter-
national best practice is not always followed.
Total expenditure on health has increased both in ab-
solute terms and as a percentage of national income. As
in all health systems these increases can be explained on
the basis of population growth, aging of the population,
advances in technology and price inflation. In the UAE,
the increases may also be justified if there was previously
unmet need that is now being met. However in our re-
view we found researchers who suspected over-use,
waste and fraud and who questioned whether the in-
creases in activity and cost were sustainable or whether
further reforms were required. In the review, a recurring
theme was the need to economize on drug costs by en-
couraging greater use of generic products. In our review
we were surprised that, given the excellence of the UAE
health system, substantial numbers of patients are
funded to have medical treatment abroad at substantial
cost. This is all the more noteworthy because the UAE
health system is highly successful at attracting incoming
medical tourists. The reasons for this curious state of af-
fairs was not explored in depth but if the UAE’s ambi-
tion to have a world class health system is fully achieved
then funding patients to receive routine treatment
abroad would seem to be improvident. In the review we
found discussion of the percentage of total health ex-
penditure that is contributed by out-of-pocket (OOP)
expenses, a widely used metric to indicate financial se-
curity. In the UAE, the OOP percentage is comparable
to that seen in other countries with well-developed pro-
gressive health systems. This might appear surprising
given the high levels of disposable income enjoyed by
many UAE citizens and expatriates. However, once again
our review highlighted the need to improve the quality of
data collection and reporting and to make allowance for
the fact that the UAE population is very heterogeneous.
In this review, we found that a normative approach
was typically adopted to plan and predict future capacity
both for hospital bed numbers and numbers of doctors,
nurses and other healthcare staff. The norms or bench-
marks that are used are those from North America and
Europe. It is not clear if there is shortage or oversupply
or what, if any, are the consequences of this. What is
clear from published evidence is the high staff turnover
and poor retention rates.
From our review, it is not possible to say if the UAE
health systems reforms are working. Some researchers
have concluded that it is too early to expect to see any
effect but mostly the research in this area has not fo-
cused specifically on this question. We found isolated re-
ports of initiatives that have improved quality. UAE
national policy is that all hospitals should be JCI accre-
dited and good progress is being made towards this tar-
get. Again, there are a few reports of the beneficial
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effects of accreditation but this is an area that is poorly
researched. We found isolated examples of where ser-
vices or programs had been audited against international
best practice benchmarks with mixed findings. Where
researchers commented on patient satisfaction with ser-
vices this was usually high.
Despite the increased focus on healthcare reforms in
many countries, it remains a concept lacking a clear def-
inition [9]. According to one definition, health system
reform can be described as a “significant purposive ef-
fort to improve the performance of the health care sys-
tem” [52]. With respect to the impact of reforms,
several authors have cautioned against simplistic, cause-
and-effect logic because of the complexities involved in
overseeing and providing healthcare with multiple, de-
manding stakeholders, competing political priorities
and high expectations [53, 54]. However, despite this
caution, over the last three decades, global institutions
such as the World Health Organization and the World
Bank have stimulated national government to reform
their health systems, with notable results [55].. For ex-
ample, governments of developing countries, such as
Brazil, Russia, India, China and South Africa have com-
mitted themselves to radical reform programs with the
goal of achieving universal health coverage and China in
particular has made significant progress in ensuring that
its population has access to healthcare [56, 57]. Simi-
larly, the Affordable Care Act in the US has resulted in
an impressive decrease in the percentage of uninsured
adults [58].. Specifically to the Middle East and North
Africa region, researchers have commented on the in-
creased focus on building or reforming health insurance
systems as a popular method of reform [59].
This is the most complete summary, to date, of the
evidence available on the progress and outcomes of
health systems reform in the United Arab Emirates. Our
study is not without limitations. We found a limited
number of studies that addressed UAE health system re-
form and of those that did most lacked robust method-
ology and failed to focus on the outcomes of reform.
Although our search strategy was broad and included
both published and unpublished sources to minimize
publication bias it is possible that papers meeting our in-
clusion criteria were missed and therefore, not included
in the review. Nevertheless, the review provides a stock-
take or baseline from which future researchers can plan
and develop their research questions. We have identified
some important gaps in knowledge that may inform fu-
ture research.
Conclusion
The UAE government is committed to build a world class
health system to improve the quality of healthcare health
outcomes for its population. To achieve this it has
implemented extensive health system reforms in the past
10 years including the introduction of mandatory private
health insurance, the development of the private sector and
the separation of planning and regulatory responsibilities
from provider functions. From the existing research litera-
ture it is not possible to conclude whether the reforms are
working although there are some positive indications in-
cluding high patient satisfaction, increasing coverage of JCI
accreditation and isolated examples of quality improve-
ment. We recommend that research should continue in
this area but that research questions should be more clearly
defined focusing whenever possible on outcomes rather
than processes. In addition there is need for better quality
data collection and reporting to allow the health needs and
outcomes of specific population sub-groups to be defined.
Finally there is scope to align services and program more
closely with international best practice and to benchmark
UAE performance with that of similar highly developed,
progressive health systems from around the world.
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